Overview
Status
Active
Registry date
2005-08-23
Share capital
50,000.00 PLN
Registered address
ul. Bukowa 15, 02-708 Warszawa, Poland
Financials
Only balance sheet data (assets and liabilities) is available. The income statement (P&L) is not available in the source filing for this period.
Revenue history
Filing timeliness
No financial statement for 2025 – the filing deadline has passed. 3 of 6 financial statements were filed late (the longest delay 577 days for 2022), 2 not filed.
- 2025not filed
- 202411/05/2026
- 202311/02/2025
- 202211/02/2025
- 2021not filed
- 2020not filed
Filed on timeDelayFiling deadline
The statements for 2022–2023 report only zeros (no activity).
Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.
Industry
Authorized Representatives
Katarzyna Agata Koziak – Management Board Member
Manner of representation
In the case of a one-person management board, each member of the management board independently; in the case of a multi-member management board, two members of the management board jointly.
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
Katarzyna Agata Koziakage 59 | 100 | $13,506.21 | 100% |
Beneficial owners
No beneficial owners recorded for the company Wekzmed.
Debt
No entries in the National Debtors Register (KRZ).
Public aid
No public aid cases recorded in the last 10 years.
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| Państwowy Instytut Medyczny Ministerstwa Spraw Wewnętrznych i AdministracjiResearch institute | $355,967,543.57 | cskmswia.pl | ||
| FamicordtxS.A. | $1,365,068.41 | famicordtx.com | ||
| Orphinic ScientificS.A. | $518,429.97 | orphinic.com | ||
| Medicofarma BiotechS.A. | $314,882.33 | medicofarmabiotech.pl | ||
| Explorna Therapeuticssp. z o.o. | $304,662.00 | explorna.com | ||
| Frontline BiosciencesS.A. | $219,186.29 | frontlinebiosciences.com | ||
| Stenocoatsp. z o.o. | $36,665.21 | stenocoat.com | ||
| Bioselsp. z o.o. | $19,100.32 | selol.pl | ||
| Nawah Scientific Polandsp. z o.o. | – | nawah-scientific.com | ||
| LASTsp. z o.o. | – | last-skincare.com |
Change history
| Date | Event | |
|---|---|---|
| 2021-05-01 | Business resumed | |
| 2019-05-01 | Business suspended | |
| 2019-03-01 | Address change (Paszkiewicza 4/16, 02-798, Warszawa → Ul. Bukowa 15, 02-708, Warszawa) | |
| 2019-03-01 | Switch to PKD 2007 (45 PKD 2004 codes → 10 PKD 2007 codes) | |
| 2005-08-23 | Entered in the register |
FAQ
The main business activity of Wekzmed focuses on research and experimental development on biotechnology.
The company was registered in the Polish National Court Register (KRS) on August 23, 2005.
The headquarters is located at: ul. Bukowa 15, 02-708 Warszawa.
The share capital of the company is PLN 50,000 (approx. $13,506).
The latest available financial statement covers the period from January 1, 2024 to December 31, 2024.
Last updated: 2026-10-07